‘Going Digital’ Is Changing Pharma’s Processes, People And Culture
It Is Not Easy Or Quick, But Nor Is It Optional
Executive Summary
Digital must become a core capability for pharma if it is to remain competitive. New technologies bring faster innovation cycles, but demand new kinds of expertise and partnerships that threaten traditional hierarchies and mindsets. The rewards, for pharma, are most likely to come from improved efficiency and stronger relationships with stakeholders, rather than from digital end-products.